AR089703A1 - Derivados de arilamida que tienen propiedades antiandrogenicas - Google Patents

Derivados de arilamida que tienen propiedades antiandrogenicas

Info

Publication number
AR089703A1
AR089703A1 ARP130100091A ARP130100091A AR089703A1 AR 089703 A1 AR089703 A1 AR 089703A1 AR P130100091 A ARP130100091 A AR P130100091A AR P130100091 A ARP130100091 A AR P130100091A AR 089703 A1 AR089703 A1 AR 089703A1
Authority
AR
Argentina
Prior art keywords
derivatives
arilamide
trifluoromethyl
hydrogen
formula
Prior art date
Application number
ARP130100091A
Other languages
English (en)
Original Assignee
Medeia Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medeia Therapeutics Ltd filed Critical Medeia Therapeutics Ltd
Publication of AR089703A1 publication Critical patent/AR089703A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Los derivados de arilamida de la fórmula (1) tienen propiedades antiandrogénicas. La presente también se refiere a los compuestos de la fórmula (1) para utilizar como un medicamento y a composiciones farmacéuticas que los comprenden y a su preparación. Reivindicación 1: Un derivado de arilamida que tiene la fórmula (1) y estereoisómeros y sales farmacéuticamente aceptables de los mismos; donde R² es halo o trifluorometilo; y R⁸ y R⁹ se seleccionan del grupo que consta de hidrógeno, halo y trifluorometilo, siempre que al menos uno de R⁸ y R⁹ sea distinto de hidrógeno; y R¹¹ es alquilo C₃₋₅ ramificado o cicloalquilo C₃₋₆; siempre que cuando R¹¹ es isopentilo, R² es trifluorometilo y R⁹ es hidrógeno, luego R⁸ no es flúor.
ARP130100091A 2012-01-13 2013-01-11 Derivados de arilamida que tienen propiedades antiandrogenicas AR089703A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20125041 2012-01-13

Publications (1)

Publication Number Publication Date
AR089703A1 true AR089703A1 (es) 2014-09-10

Family

ID=47678880

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130100091A AR089703A1 (es) 2012-01-13 2013-01-11 Derivados de arilamida que tienen propiedades antiandrogenicas

Country Status (3)

Country Link
AR (1) AR089703A1 (es)
TW (1) TW201332953A (es)
WO (1) WO2013104831A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016079521A1 (en) * 2014-11-20 2016-05-26 University College Cardiff Consultants Limited Androgen receptor modulators and their use as anti-cancer agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE28864T1 (de) 1982-07-23 1987-08-15 Ici Plc Amide-derivate.
KR20090030345A (ko) 2006-07-19 2009-03-24 더 오하이오 스테이트 유니버시티 리서치 파운데이션 선택적인 안드로겐 수용체 모듈레이터, 그 유사체와 유도체, 및 그의 용도
ITBO20090078A1 (it) 2009-02-13 2010-08-14 Consiglio Nazionale Ricerche Composti per il trattamento del tumore alla prostata e procedimenti per la loro sintesi
EP2424853B1 (en) 2009-04-10 2018-09-19 Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori (I.R.S.T.) S.R.L. Non-steroidal compounds for androgen receptor modulation, processes for the preparation and uses thereof
FI20105806A0 (fi) * 2010-07-15 2010-07-15 Medeia Therapeutics Ltd Uudet aryyliamidijohdannaiset, joilla on antiandrogeenisia ominaisuuksia

Also Published As

Publication number Publication date
WO2013104831A1 (en) 2013-07-18
TW201332953A (zh) 2013-08-16

Similar Documents

Publication Publication Date Title
CY1124404T1 (el) Παραγωγα χολικου οξεος ως αγωνιστες fxr/tgr5 και μεθοδοι χρησης αυτων
PH12020550552A1 (en) Inhibitors of hepatitis c virus
CL2017001675A1 (es) Derivados de quinazolina utilizados para tratar el vih
MX390302B (es) Oxiesteroles y metodos de uso de los mismos
EA201591195A1 (ru) Новые хинолоновые производные
MX389349B (es) Derivados de ácido borónico y usos terapéuticos de los mismos.
NZ739760A (en) Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
EA201390008A1 (ru) Новые ариламидные производные, обладающие антиандрогенными свойствами
ECSP12012103A (es) Inhibidores de virus flaviviridae.
EA201590023A1 (ru) Новые 4-замещенные производные 1,3-дигидро-2h-бензимидазол-2-она, замещенные бензимидазолами, в качестве противовирусных средств против респираторного синцитиального вируса
GEP201706671B (en) Heterocyclyl compounds as mek inhibitors
MX2020010690A (es) Oxiesteroles y metodos de uso de los mismos.
MX382991B (es) Inhibidores de la arginina metiltransferasa y usos de los mismos.
MD20160012A2 (ro) Formulare de inhibitori SYK
EP4643945A8 (en) Neuroactive steroids and methods of use thereof
BR112015000106A2 (pt) moduladores heterocíclicos de síntes de lipídio
GEP20176631B (en) Alkoxy pyrazoles as soluble guanylate cyclase activators
MX2011010415A (es) Formulaciones farmaceuticas que comprenden derivados de nitrocatecol y metodos para hacer las mismas.
EP4316591A3 (en) Oxysterols and methods of use thereof
EA201690888A1 (ru) Новые гетероциклические соединения
MX381967B (es) Compuestos de 2,3-dihidrobenzofuran-5-ilo como inhibidores de quinasas dyrk.
EA201590022A1 (ru) Новые производные 1,3-дигидро-2h-бензимидазол-2-она, замещенные гетероциклами, в качестве противовирусных средств против респираторного синцитиального вируса
CR20180138A (es) Piridinona dicaboxamidas para uso como inhibidores de bromodominio
GT201400044A (es) 2-(croman-6-iloxi)-tiazoles sustituidos y su uso como productos farmacéuticos
EA201491364A1 (ru) Новые гетероариламидные производные, обладающие антиандрогенными свойствами

Legal Events

Date Code Title Description
FB Suspension of granting procedure